CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-01 | Onyia Jude Chief Scientific Officer | Option exercise 10b5-1 | +11,000 | $84.74 | $932K | 36,846 |
| 2026-06-01 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −11,000 | $160.25 | $1.8M | 25,846 |
| 2026-06-01 | Onyia Jude Chief Scientific Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −11,000 | 13,268 | ||
| 2026-05-29 | Delaet Ingrid Chief Regulatory Officer | Option exercise 10b5-1 | +2,261 | $79.02 | $179K | 18,486 |
| 2026-05-29 | Delaet Ingrid Chief Regulatory Officer | Sale 10b5-1 | −2,261 | $156.71 | $354K | 16,225 |
| 2026-05-29 | Delaet Ingrid Chief Regulatory Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −2,261 | 0 | ||
| 2026-05-27 | Onyia Jude Chief Scientific Officer | Option exercise 10b5-1 | +11,000 | $84.74 | $932K | 36,846 |
| 2026-05-27 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −11,000 | $155.53 | $1.7M | 25,846 |
| 2026-05-27 | Onyia Jude Chief Scientific Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −11,000 | 24,268 | ||
| 2026-05-27 | Mercier Johanna Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 | ||
| 2026-05-27 | Norwalk Leslie V Director | Grant or award · Restriced Stock Unit | +1,284 | 1,284 | ||
| 2026-05-27 | Norwalk Leslie V Director | Grant or award · Non-Qualified Stock Option | +2,624 | 2,624 | ||
| 2026-05-27 | Sharp Shalini Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 | ||
| 2026-05-27 | RASTETTER WILLIAM H Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 | ||
| 2026-05-27 | GORMAN KEVIN CHARLES Director | Grant or award · Non-Qualified Stock Option | +5,248 | 5,248 | ||
| 2026-05-27 | POON CHRISTINE A Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 | ||
| 2026-05-27 | POPS RICHARD F Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 | ||
| 2026-05-27 | LYONS GARY A Director | Grant or award · Restriced Stock Unit | +1,284 | 1,284 | ||
| 2026-05-27 | LYONS GARY A Director | Grant or award · Non-Qualified Stock Option | +2,624 | 2,624 | ||
| 2026-05-27 | SHERWIN STEPHEN A Director | Grant or award · Restriced Stock Unit | +2,567 | 2,567 |
Page 6 of 37 · 740 trades